According to the recent report by IMARC Group, titled “Hemoglobin Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the market is currently witnessing strong growth. A hemoglobin (Hgb) test determines the level of hemoglobin or the count of red blood cells (RBC) in the blood. Hemoglobin is a type of protein present in the RBCs that transports oxygen from the lungs to the tissues and organs, and then carries carbon dioxide back to the lungs. A hemoglobin test can be performed by the doctors as a part of a patient’s routine checkup. If the examination reveals low levels of hemoglobin than the standard range, then that means the body is prone to anemia and if it is higher, then it can be a symptom of other disorders. Subsequently, the doctors prescribe medicines and dietary changes to maintain an optimum level of hemoglobin in the body.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Get a sample copy of this Report: https://www.imarcgroup.com/hemoglobin-testing-market/requestsample
Global Hemoglobin Testing Market Trends:
Fast-paced lifestyles of the working population have led to irregular mealtime and increased the dependence on ready-to-eat food. Improper diet and stress have led to a rise in the number of chronic diseases, like diabetes and anemia, thereby propelling the demand for hemoglobin testing. Moreover, the provision of home care testing by several healthcare centers has made the test more convenient for users as they get doorstep services of collecting samples and faster results. Apart from this, the development of advanced hemoglobin testing equipment is spurring the market growth. For instance, a mobile health app called Mhematology has been introduced that allows users to measure their hemoglobin levels from the comforts of their home. This non-invasive method offers faster results than the traditional method. Furthermore, the outbreak of the coronavirus disease (COVID-19) has bolstered the growth of telemedicine and mobile health services, which, in turn, is creating a positive outlook for the market. This is further supported by the rising number of FDA approvals for novel hemoglobin tests. For instance, HemoCue received clearance from the USFDA for its point-of-care testing product in February 2020. Looking forward, IMARC Group expects the global hemoglobin testing market to grow at a CAGR of 6.80% during 2021-2026.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/hemoglobin-testing-market
Competitive Landscape with Key players:
The report has also analysed the competitive landscape of the market with some of the key players being.
- Abbott
- Bio-Rad Laboratories
- Danaher
- EKF Diagnostics
- Hoffmann-La Roche
- Siemens Healthineers
- Thermo Fisher Scientific
- Alere
- ACON Laboratories
- ARKRAY
- Bayer Medical Care
- Daiichi Biotech
- DiaSys Diagnostic Systems
- Epinex Diagnostics
- Erba Diagnostics
Hemoglobin Testing Market Segmentation:
Our report has categorized the market based on region, product type, technology and end-user.
Market Breakup by Product Type:
- Reagents and Consumables
- Equipment
Market Breakup by Technology:
- Chromatography
- Immunoassay
- Other
Market Breakup by End-User:
- Laboratories
- Hospitals
- Research centers
Market Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Hemoglobin testing is the process of carrying out diagnostic tests to detect the levels of hemoglobin in the patient’s blood.
Hemoglobin’s importance for providing essential nutrients and oxygen to the human body is immeasurable and hence the requirement for accurate monitoring and detection of hemoglobin levels is essential.
These tests generally do not require any special requests and can be carried out on the blood samples extracted from the patient.Market Analysis: Global Hemoglobin Testing MarketGlobal hemoglobin testing market is expected to register a substantial CAGR of 8.68% in the forecast period of 2019-2026.
The report contains data from the base year of 2018 and the historic year of 2017.
This rise in market value can be attributed to the accurate detection of various other diseases prevalent with low hemoglobin levels.Top Market Competitors:Few of the major competitors currently working in the global hemoglobin testing market are Abbott; Bio-Rad Laboratories, Inc.; Danaher; F. Hoffmann-La Roche Ltd; EKF Diagnostics; Siemens Healthcare GmbH; Thermo Fisher Scientific Inc.; ACON Laboratories, Inc.; Biomedomics Inc; Hemosure, Inc.; HUMASIS.COM; Immunostics Inc.; Germaine Laboratories, Inc.; Portea Medical; LifeSign LLC; Medixbiochemica; NanoEnTek Inc.; Quidel Corporation; Rtalabs; SA Scientific; TCS Biosciences Ltd.; Biohit Oyj; Microgen; Nova Biomedical and STRECK, INC. among others.Segmentation: Global Hemoglobin Testing MarketBy TechnologyChromatographyImmunoassayOthersBy End-UsersHospitalsResearch CentersLaboratoriesOthersBy Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)Market DriversIncreasing prevalence of diabetic population globally is expected to positively affect the growth of the marketRising prevalence of home-based diagnostic tests is expected to drive the growth of the marketAdvancements in technology resulting in rapid result detection is also expected to positively affect the growth of the marketMarket RestraintsHigh levels of costs associated with the medical devices and concerns regarding the high maintenance costs of these systems is expected to hinder its adoption rateAbsence of detection of other molecular components other than hemoglobin levels with this tests is expected to hinder the growth of the marketThe Detailed statistical analysis data is given or represented in Tabular format, Pie Charts, Graphs.
Get Free Sample Report Copy of hemoglobin testing Market @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-hemoglobin-testing-market Competitive Analysis:Global hemoglobin testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
The market insights of Hemoglobin Testing Market report helps businesses obtain granular level clarity on current business trends and expected future developments.
For this, market data is broken down in a systematic process to highlight focus areas of client’s interest.
For producing such excellent market research report, principal attributes such as highest level of spirit, practical solutions, dedicated research and analysis, innovation, talent solutions, integrated approaches, most advanced technology and commitment plays a key role.A numerous markets, marketing strategies, trends, future products and rising opportunities have been considered while studying market for preparing an all-inclusive Hemoglobin Testing marketing report.Get Download Free Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hemoglobin-testing-marketTop Key Players of this Global Hemoglobin Testing Market –Abbott, Bio-Rad Laboratories, Inc., Danaher, F. Hoffmann-La Roche Ltd, EKF Diagnostics, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., ACON Laboratories, Inc., BIOMEDOMICS INC., Hemosure, Inc., Humasis Co., Ltd., Immunostics Inc., Germaine Laboratories, Inc., Portea Medical, LifeSign LLC, Medix Biochemica, Nanoentek, Quidel Corporation, TCS Biosciences Ltd., and Nova Biomedical among other domestic and global playersThe company profiles of all the major players and brands that are dominating the market are covered in the report with respect to their moves like product launches, joint ventures, mergers and acquisitions.
The Hemoglobin Testing Market research report also explains in depth description, competitive scenario, product portfolio of key vendors and their business strategies with the help of SWOT analysis and porter's five force analysis.Segmentation of the Global Hemoglobin Testing Market –Hemoglobin Testing Market by Product Type -Automated Hematology AnalyzersPoint-of-CareReagentsConsumablesHemoglobin Testing Market by Technology –ChromatographyImmunoassayOthersHemoglobin Testing Market by End Users –HospitalsResearch CentersLaboratoriesDiagnostic CentersHomecare SettingsOthersFurther, leading factors such as market drivers, market restraints and competitive analysis are examined with the SWOT analysis which is the most established tool for generating market research report.
While generating this Hemoglobin Testing Market report, markets on the local, regional as well as global level are explored.Get Detailed Toc and Charts & Tables @ https://www.databridgemarketresearch.com/toc/?dbmr=global-hemoglobin-testing-marketfollowing key questions addressed through this research report:What are the drivers of the global Hemoglobin Testing market?Which factors are restraining the growth of the global Hemoglobin Testing market?What are the major key players in the global Hemoglobin Testing market?What are the effective sales methodologies?This market report offers an actionable market insight with which sustainable and profitable business strategies can be built.
A large-scale Hemoglobin Testing Market report has been prepared by conducting market research in a systematic manner.Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa)Want Full Report?
Driving producers of restorative gadgets are expected to be enter in the worldwide rise of the glycated hemoglobin testing market.
Organizations specifically, Bio-Rad Laboratories, Bayer, Arkray, Chek Diagnostics, Diazyme Laboratories, X Lite-On Technology, TaiDoc Technology, Trinity Biotech, Siemens Healthcare, Ceragem Medisys, Tosoh Bioscience, DiaSys Diagnostic Systems, Erba Mannheim, Daiichi Biotech, Human Diagnostics, EKF Diagnostics, Mindray Medical, Sebia, and Randox Laboratories are relied upon to be seen as driving producers of gadgets utilized as a part of glycated hemoglobin tests.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=35429 As indicated in a report by Transparency Market Research (TMR), the worldwide market for glycated hemoglobin testing is anticipated to be somewhere worth US$ 705 mn before the year 2026.
The worldwide glycated hemoglobin testing market, North America is relied upon to command as far as worldwide revenue share.
Additionally, the utilization of these procedures will depend mainly upon the end-utilization of glycated hemoglobin tests.Request COVID Analysis on Glycated Hemoglobin Testing Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=35429 Point-of-care Segment to Dominate the Other Test Segments in the Global MarketPatients looking for glycated hemoglobin testing are developing more slant towards research center based tests.
While point-of-care glycated hemoglobin testing is comparatively more advantageous choice, the outcomes and symptomatic results of research facilities keep on spearheading their strength in the worldwide market.
The report additionally uncovers that healing facilities are likely to be the biggest end-clients of glycated hemoglobin testing in the worldwide market.
